New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BAC;AAPL;MRK;HMY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
November 11, 2014
08:15 EDTAAPLAlibaba says willing to collaborate with PayPal in future, Bloomberg reports
Subscribe for More Information
08:10 EDTMRKMerck reports results from Phase 2 study of Grazoprevir/Elbasvir
Subscribe for More Information
07:35 EDTAAPLApple price target raised to $125 from $115 at UBS
Subscribe for More Information
06:59 EDTBACBank of America's head of FICC trading to retire by year-end, WSJ reports
Bank of America's head of global fixed income, currencies and commodities trading trading, David Sobotka, will retire by year-end, the Wall Street Journal reports, citing an internal memo sent to employees. Sobotka is planning to take some time off before deciding on his next steps. Sources say BofA will name Sobotka's replacement by the end of the year. Reference Link
06:31 EDTAAPLApple making aggressive move into corporate market, Reuters says
Subscribe for More Information
06:03 EDTAAPLQ4 global tablet shipments estimated at 74.5M units, DigiTimes reports
Subscribe for More Information
November 10, 2014
16:00 EDTAAPLOptions Update; November 10, 2014
Subscribe for More Information
12:42 EDTAAPLFireEye details hack attack found on Apple operating system
Subscribe for More Information
12:39 EDTAAPLFireEye has uncovered iOS flaw that leaves devices vulnerable, CNBC reports
Subscribe for More Information
09:35 EDTAAPLActive equity options trading
Subscribe for More Information
09:20 EDTMRKOn The Fly: Pre-market Movers
Subscribe for More Information
08:48 EDTMRKGilead rises after Merck presents data on HCV combo
Subscribe for More Information
07:34 EDTAAPLApple Pay seen making up 1% of Whole Foods transactions since launch, Dudas says
Subscribe for More Information
07:20 EDTMRKGilead overhang from Merck HCV combo removed, says Wells Fargo
Subscribe for More Information
06:53 EDTBACBank of America, U.S. Bancorp settle bond trustee class action, Reuters says
Subscribe for More Information
06:46 EDTBACRegulators set new capital buffer rule for banks, Reuters reports
Global banks should have buffers of bonds or equity worth 16%-20% of their risk-weighted assets, beginning in January 2019, The Financial Stability Board decided, according to Reuters. The board said the buffer would prevent the need for government bailouts, the news service explained. Publicly traded global banks include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) Wells Fargo (WFC), Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), RBS (RBS) and UBS (UBS). Reference Link
06:27 EDTAAPLGT Advanced accuses Apple of 'bait-and-switch' in unsealed documents, WSJ says
Subscribe for More Information
06:00 EDTAAPLApple implied volatility of 19 at lower end of index mean range
Subscribe for More Information
November 9, 2014
18:58 EDTMRKMerck presents interim data from C-SWIFT study
Merck announced the presentation of interim data from the C-SWIFT study exploring the potential of a candidate triple-therapy regimen consisting of the fixed-dose combination of grazoprevir/elbasvir , the company’s investigational NS3/4A protease inhibitor and NS5A inhibitor, in combination with sofosbuvir, a nucleotide inhibitor for the treatment of chronic hepatitis C virus, HCV, infection. Preliminary findings in treatment-naïve HCV genotype 1- infected non-cirrhotic patients, following six and four weeks of treatment, and patients with cirrhotic disease, following eight and six weeks of treatment, will be presented by Dr. Eric Lawitz, vice president, scientific and research development, The Texas Liver Institute, San Antonio, TX and C-SWIFT lead investigator. This poster presentation is part of a late-breaking abstract session at the 65th American Association for the Study of Liver Diseases, AASLD, Annual Meeting, also known as The Liver Meeting. “These interim data provide a compelling proof-of-concept for the potential of an eight- or six-week triple therapy course in treatment-naive patients with genotype 1 disease, including cirrhotic patients,” said Dr. Lawitz. “These findings will inform the design of larger studies aimed at understanding the potential of short-duration triple therapy across multiple patient types.”
13:00 EDTBACBofA looks for additional SEC sanctions to be waved, Bloomberg says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use